Cargando…
Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases
BACKGROUND AND AIMS: To explore the long-term trend of liver cancer survival, based on the real-world data (RWD) in the past 45 years from a population-based cancer registry, in Qidong, China. METHODS: A number of 32,556 patients with liver cancer were registered during the period of 1972 to 2016. M...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418373/ https://www.ncbi.nlm.nih.gov/pubmed/34513745 http://dx.doi.org/10.2147/JHC.S321346 |
_version_ | 1783748565460320256 |
---|---|
author | Chen, Jian-Guo Zhu, Jian Zhang, Yong-Hui Chen, Yong-Sheng Ding, Lu-Lu Chen, Hai-Zhen Shen, Ai-Guo Wang, Gao-Ren |
author_facet | Chen, Jian-Guo Zhu, Jian Zhang, Yong-Hui Chen, Yong-Sheng Ding, Lu-Lu Chen, Hai-Zhen Shen, Ai-Guo Wang, Gao-Ren |
author_sort | Chen, Jian-Guo |
collection | PubMed |
description | BACKGROUND AND AIMS: To explore the long-term trend of liver cancer survival, based on the real-world data (RWD) in the past 45 years from a population-based cancer registry, in Qidong, China. METHODS: A number of 32,556 patients with liver cancer were registered during the period of 1972 to 2016. Mixed methods by active and passive follow-up were performed. Life table method was employed for survival analysis by SPSS22 software. Wilcoxon (Gehan) statistics was considered as a significant test. Relative survival was calculated by using SURV software, and its annual percent change (APC) was estimated by the Joinpoint Regression Program. RESULTS: The overall observed survival (OS) rates of 1-, 5-, 10-, and 20-year rates from the data series were 18.51%, 6.28%, 4.03%, and 2.84%, and their relative survival (RS) rates were 18.88%, 6.95%, 4.96%, and 4.49%, respectively. For 24,338 male cases, the 5-year OS and RS rates were 5.93% and 6.54%, and for 8218 female cases, 7.34% and 8.15%, respectively, with P values less than 0.01. Survival rates of liver cancer from three 15-year periods of 1972–1986, 1987–2001, and 2002–2016 have increased significantly, with 5-year OS rates of 2.02%, 4.40%, and 10.76%, 5-year RS rates of 2.18%, 4.83%, and 12.18%; 10-year OS and RS rates of 0.95%, 3.00%, and 7.02%, vs 1.13%, 3.65%, and 8.96%, respectively, showing a very significant upward trend (P<0.01). There are significant differences among age groups (P<0.01): those aged 55–64 demonstrated the best OS and RS rates of 5-year, being 8.44% and 9.09%, respectively. CONCLUSION: There are significant gender and age differences in the survival rate of liver cancer in Qidong. RWD indicates the relative lower survival rate of liver cancer in this area, but great improvement has been achieved over the past decades. |
format | Online Article Text |
id | pubmed-8418373 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-84183732021-09-09 Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases Chen, Jian-Guo Zhu, Jian Zhang, Yong-Hui Chen, Yong-Sheng Ding, Lu-Lu Chen, Hai-Zhen Shen, Ai-Guo Wang, Gao-Ren J Hepatocell Carcinoma Original Research BACKGROUND AND AIMS: To explore the long-term trend of liver cancer survival, based on the real-world data (RWD) in the past 45 years from a population-based cancer registry, in Qidong, China. METHODS: A number of 32,556 patients with liver cancer were registered during the period of 1972 to 2016. Mixed methods by active and passive follow-up were performed. Life table method was employed for survival analysis by SPSS22 software. Wilcoxon (Gehan) statistics was considered as a significant test. Relative survival was calculated by using SURV software, and its annual percent change (APC) was estimated by the Joinpoint Regression Program. RESULTS: The overall observed survival (OS) rates of 1-, 5-, 10-, and 20-year rates from the data series were 18.51%, 6.28%, 4.03%, and 2.84%, and their relative survival (RS) rates were 18.88%, 6.95%, 4.96%, and 4.49%, respectively. For 24,338 male cases, the 5-year OS and RS rates were 5.93% and 6.54%, and for 8218 female cases, 7.34% and 8.15%, respectively, with P values less than 0.01. Survival rates of liver cancer from three 15-year periods of 1972–1986, 1987–2001, and 2002–2016 have increased significantly, with 5-year OS rates of 2.02%, 4.40%, and 10.76%, 5-year RS rates of 2.18%, 4.83%, and 12.18%; 10-year OS and RS rates of 0.95%, 3.00%, and 7.02%, vs 1.13%, 3.65%, and 8.96%, respectively, showing a very significant upward trend (P<0.01). There are significant differences among age groups (P<0.01): those aged 55–64 demonstrated the best OS and RS rates of 5-year, being 8.44% and 9.09%, respectively. CONCLUSION: There are significant gender and age differences in the survival rate of liver cancer in Qidong. RWD indicates the relative lower survival rate of liver cancer in this area, but great improvement has been achieved over the past decades. Dove 2021-08-31 /pmc/articles/PMC8418373/ /pubmed/34513745 http://dx.doi.org/10.2147/JHC.S321346 Text en © 2021 Chen et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Chen, Jian-Guo Zhu, Jian Zhang, Yong-Hui Chen, Yong-Sheng Ding, Lu-Lu Chen, Hai-Zhen Shen, Ai-Guo Wang, Gao-Ren Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases |
title | Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases |
title_full | Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases |
title_fullStr | Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases |
title_full_unstemmed | Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases |
title_short | Liver Cancer Survival: A Real World Observation of 45 Years with 32,556 Cases |
title_sort | liver cancer survival: a real world observation of 45 years with 32,556 cases |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418373/ https://www.ncbi.nlm.nih.gov/pubmed/34513745 http://dx.doi.org/10.2147/JHC.S321346 |
work_keys_str_mv | AT chenjianguo livercancersurvivalarealworldobservationof45yearswith32556cases AT zhujian livercancersurvivalarealworldobservationof45yearswith32556cases AT zhangyonghui livercancersurvivalarealworldobservationof45yearswith32556cases AT chenyongsheng livercancersurvivalarealworldobservationof45yearswith32556cases AT dinglulu livercancersurvivalarealworldobservationof45yearswith32556cases AT chenhaizhen livercancersurvivalarealworldobservationof45yearswith32556cases AT shenaiguo livercancersurvivalarealworldobservationof45yearswith32556cases AT wanggaoren livercancersurvivalarealworldobservationof45yearswith32556cases |